Q3 2025 Holdings
Filed 2025-11-14 | 34 holdings | $313.7M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2026-02-17) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $82.1M | 9,771,485 | 26.2% |
| Uniqure NV(QURE) | SHS | N90064101 | $46.7M | 800,000 | 14.9% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $18.7M | 400,000 | 6.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $18.1M | 319,100 | 5.8% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $12.3M | 750,000 | 3.9% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $12.3M | 200,000 | 3.9% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $12.2M | 900,000 | 3.9% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $11.5M | 575,000 | 3.7% |
| Merus N V | COM | N5749R100 | $11.3M | 120,000 | 3.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $11.0M | 200,000 | 3.5% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $10.2M | 120,000 | 3.2% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $7.3M | 110,000 | 2.3% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $7.1M | 125,000 | 2.3% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $5.4M | 453,686 | 1.7% |
| Inovio Pharmaceuticals Inc(INO) | COM SHS | 45773H409 | $5.4M | 2,300,000 | 1.7% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $4.8M | 250,000 | 1.5% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $4.6M | 48,000 | 1.5% |
| Celcuity Inc(CELC) | COM | 15102K100 | $4.4M | 90,000 | 1.4% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $4.4M | 1,050,000 | 1.4% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $3.7M | 600,000 | 1.2% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $3.6M | 250,000 | 1.2% |
| Precigen Inc(PGEN) | COM | 74017N105 | $2.8M | 850,000 | 0.9% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $2.0M | 50,000 | 0.6% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $1.9M | 163,500 | 0.6% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $1.8M | 250,000 | 0.6% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $1.6M | 175,000 | 0.5% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $1.6M | 125,000 | 0.5% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $1.3M | 666,666 | 0.4% |
| Pepgen Inc(PEPG) | COM | 713317105 | $1.2M | 250,000 | 0.4% |
| LB Pharmaceuticals Inc(LBRX) | COM SHS | 50180M108 | $1.1M | 70,000 | 0.4% |
| Instil BIO Inc(TIL) | COM NEW | 45783C200 | $1.1M | 60,700 | 0.3% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $248.5K | 20,400 | 0.1% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 02/10/202 | 67080N119 | $53.9K | 266,666 | 0.0% |
| Surrozen Inc(SRZNW) | *W EXP 08/01/203 | 86889P117 | $1.0K | 66,666 | 0.0% |